Outcomes and Risk Factors for Liver Transplantation Using Significant Fibrotic Grafts

Zhejiang University

Status: Completed

Conditions: Liver Transplant

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT07101718

CT-2025-ZJU-OBS07

Details and patient eligibility

About

This is a multi-center study to investigate the impact of fibrotic liver greafts in liver transplant recipient.

Enrollment: 25,419 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

patients receiving liver transplantation during the period from March 2015 to March 2024

Exclusion criteria

1. recipients under 18 years old
2. re-transplantation cases
3. multiorgan transplant cases, reduced-size or split LT cases
4. lacking follow-up records or graft biopsy records

Trial design

25,419 participants in 3 patient groups

No fibrotic

Description:

Liver transplant recipient receiving no fibrotic liver grafts.

Treatment:

Other: No intervention

Mild fibrotic

Description:

Liver transplant recipient receiving mild fibrotic liver grafts.

Treatment:

Other: No intervention

Significant

Description:

Liver transplant recipient receiving significant fibrotic liver grafts.

Treatment:

Other: No intervention